Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
67.64
79.20
86.16
97.07
122.47
205.20
206.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
67.64
79.20
86.16
97.07
122.47
205.20
206.62
Raw Material Cost
2.34
2.37
2.97
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.94
5.15
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
55.51
50.52
42.51
29.20
23.71
22.99
20.92
Other Expenses
12.05
15.84
16.45
17.41
13.68
14.22
9.49
Total Expenditure (Excl Depreciation)
189.33
216.41
210.00
203.31
160.47
165.20
115.78
Operating Profit (PBDIT) excl Other Income
-121.7
-137.20000000000002
-123.80000000000001
-106.19999999999999
-38
40
90.8
Other Income
14.77
11.36
1.57
2.02
6.47
8.82
4.85
Operating Profit (PBDIT)
-104.59
-123.48
-119.30
-104.22
-31.52
48.82
95.70
Interest
10.94
5.15
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.07
0.00
0.08
-0.03
0.15
0.00
-0.06
Gross Profit (PBDT)
65.30
76.83
83.19
0.00
0.00
0.00
0.00
Depreciation
2.34
2.37
2.97
3.33
3.64
3.26
2.52
Profit Before Tax
-117.79
-131.00
-122.19
-107.58
-35.02
45.56
93.12
Tax
-1.74
2.82
-0.43
-28.58
1.15
-0.83
21.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-116.05
-133.82
-121.75
-79.00
-36.17
46.38
71.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-116.05
-133.82
-121.75
-79.00
-36.17
46.38
71.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-116.05
-133.82
-121.75
-79.00
-36.17
46.38
71.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
128.81
216.74
321.33
399.43
455.58
462.49
393.68
Earnings per share (EPS)
-5.49
-6.38
-5.91
-3.92
-1.81
2.21
3.48
Diluted Earnings per share
-5.49
-6.38
-5.91
-3.92
-1.81
2.21
3.48
Operating Profit Margin (Excl OI)
-179.92%
-173.23%
-143.74%
-112.88%
-34.0%
17.9%
42.75%
Gross Profit Margin
-170.7%
-162.4%
-138.36%
-107.39%
-25.62%
23.79%
46.29%
PAT Margin
-171.58%
-168.95%
-141.31%
-81.38%
-29.53%
22.6%
34.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Sep 2024 is -14.65% vs -8.12% in Sep 2023
Consolidate Net Profit
YoY Growth in year ended Sep 2024 is 13.30% vs -9.85% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Sep 2024 is 11.42% vs -11.50% in Sep 2023
Interest
YoY Growth in year ended Sep 2024 is 113.73% vs 0.00% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Sep 2024 has fallen from Sep 2023
Compare Annual Results Of Enanta Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
67.64
128.87
-61.23
-47.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
67.64
128.87
-61.23
-47.51%
Raw Material Cost
2.34
88.57
-86.23
-97.36%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.94
21.84
-10.90
-49.91%
Selling and Distribution Expenses
55.51
44.05
11.46
26.02%
Other Expenses
12.05
-1.36
13.41
986.03%
Total Expenditure (Excl Depreciation)
189.33
140.87
48.46
34.40%
Operating Profit (PBDIT) excl Other Income
-121.69
-12.01
-109.68
-913.24%
Other Income
14.77
-6.99
21.76
311.30%
Operating Profit (PBDIT)
-104.59
-10.97
-93.62
-853.42%
Interest
10.94
21.84
-10.90
-49.91%
Exceptional Items
0.07
2.16
-2.09
-96.76%
Gross Profit (PBDT)
65.30
40.30
25.00
62.03%
Depreciation
2.34
8.03
-5.69
-70.86%
Profit Before Tax
-117.79
-38.67
-79.12
-204.60%
Tax
-1.74
0.04
-1.78
-4,450.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-116.05
-38.72
-77.33
-199.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-116.05
-38.72
-77.33
-199.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-116.05
-38.72
-77.33
-199.72%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
128.81
1.34
127.47
9,512.69%
Earnings per share (EPS)
-5.49
-1.27
-4.22
-332.28%
Diluted Earnings per share
-5.49
-1.27
-4.22
-332.28%
Operating Profit Margin (Excl OI)
-179.92%
-9.32%
0.00
-170.60%
Gross Profit Margin
-170.70%
-23.78%
0.00
-146.92%
PAT Margin
-171.58%
-30.04%
0.00
-141.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6.76 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is -14.65% vs -8.12% in Sep 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -11.60 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 13.30% vs -9.85% in Sep 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -11.94 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 11.42% vs -11.50% in Sep 2023
Annual - Interest
Interest 1.09 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 113.73% vs 0.00% in Sep 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -179.92%
in Sep 2024Figures in %
YoY Growth in year ended Sep 2024 has fallen from Sep 2023






